| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(95)80007-7 |
| P698 | PubMed publication ID | 8550992 |
| P2093 | author name string | Sauer P | |
| Stiehl A | |||
| Rudolph G | |||
| Theilmann L | |||
| P2860 | cites work | Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease | Q24322810 |
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects | Q34471452 | ||
| Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity | Q37044298 | ||
| Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis | Q39514969 | ||
| Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease | Q41114391 | ||
| Influence of cholic and chenodeoxycholic acid on biliary cholesterol secretion in man. | Q41338401 | ||
| Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis | Q42192520 | ||
| Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. | Q42199158 | ||
| Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis | Q45103515 | ||
| Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. | Q51597193 | ||
| Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones | Q51624788 | ||
| Primary sclerosing cholangitis: refinement and validation of survival models | Q52409393 | ||
| Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. | Q54072767 | ||
| Biliary secretion of bile acids, lipids, and bilirubin by the transplanted liver. A quantitative study in patients on cyclosporine | Q67778218 | ||
| Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial | Q68019501 | ||
| Ursodeoxycholic acid for primary sclerosing cholangitis | Q68095108 | ||
| A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis | Q68166227 | ||
| Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids | Q68693124 | ||
| Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid | Q68842156 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
| Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? | Q69896715 | ||
| Ursodeoxycholic acid for primary biliary cirrhosis | Q69903541 | ||
| Tauroursodeoxycholate prevents taurocholate induced cholestasis | Q70316364 | ||
| Analysis of bile acid glucuronides in urine: group separation on a lipophilic anion exchanger | Q70449036 | ||
| Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis | Q70768231 | ||
| Hepatic secretion of bilirubin and biliary lipids in patients with alcoholic cirrhosis of the liver | Q71706507 | ||
| Enzymic analysis of steroid hormones | Q79283763 | ||
| P433 | issue | 3 | |
| P921 | main subject | primary sclerosing cholangitis | Q1058608 |
| lipid | Q11367 | ||
| P304 | page(s) | 283-289 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment | |
| P478 | volume | 23 |
| Q35760231 | Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis |
| Q44391213 | Cutting edge issues in primary sclerosing cholangitis |
| Q51165355 | In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment. |
| Q77373443 | Influence of cholestasis on absorption of ursodeoxycholic acid |
| Q34017604 | Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets |
| Q81724957 | Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis |
| Q37254347 | Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators? |
| Q84230884 | Primary biliary cirrhosis |
| Q44736208 | Primary sclerosing cholangitis |
| Q83905675 | The immunobiology of primary sclerosing cholangitis |
| Q35046523 | The management of primary sclerosing cholangitis |
Search more.